Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers.
Saved in:
| Title: | Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers. |
|---|---|
| Authors: | Liu X; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA., Ge Z; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang F; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Contreras A; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee S; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., White JB; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu Y; Department of Genome Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Labrie M; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Arun BK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moulder SL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mills GB; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Piwnica-Worms H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chang JT; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA. Jeffrey.T.Chang@uth.tmc.edu.; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Jeffrey.T.Chang@uth.tmc.edu. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2022 May 10; Vol. 8 (1), pp. 64. Date of Electronic Publication: 2022 May 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-022-00427-9 |
